CJC-1295 with DAC
CJC-1295 DAC is a growth hormone-releasing hormone analogue with Drug Affinity Complex, providing extended release and prolonged growth hormone elevation.
What This Compound Is
CJC-1295 with DAC is a modified GHRH analogue that includes a Drug Affinity Complex (DAC) to extend its half-life. This modification allows for sustained growth hormone release over extended periods. Researchers study this compound for its prolonged effects on GH secretion and metabolic processes in laboratory settings.
Research Interest
Scientific research on CJC-1295 with DAC examines its extended-release properties and sustained GH elevation. Studies focus on its effects on baseline growth hormone levels, IGF-1 production, protein synthesis, and body composition. Researchers investigate how the DAC modification affects pharmacokinetics, receptor binding duration, and long-term metabolic effects in experimental models.
Educational Disclaimer
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.
Available Formats
Related Research Compounds
Explore similar peptides and compounds that researchers often study together